Dashboard
Manage Tickers

LAB STANDARD BIOTOOLS INC.

Nasdaq fluidigm.com


$ 1.12 $ -0.02 (-1.75 %)    

Thursday, 06-Nov-2025 15:59:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.36 $ 0.00 (0 %)
DIA $ 469.87 $ 0.00 (0 %)
SPY $ 671.85 $ 0.00 (0 %)
TLT $ 89.41 $ 0.00 (0 %)
GLD $ 368.72 $ 0.00 (0 %)
$ 1.12
$ 1.13
$ 1.05 x 200
$ 1.30 x 1,100
-- - --
$ 0.92 - $ 2.32
1,336,793
na
430.71M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-15-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 03-10-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-01-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-14-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 03-08-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-07-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 03-18-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 03-08-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-03-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

td-cowen-maintains-hold-on-standard-biotools-lowers-price-target-to-135
TD Cowen Maintains Hold on Standard BioToo...
11/05/2025 18:35:47

TD Cowen analyst Kyle Boucher maintains Standard BioTools (NASDAQ:LAB) with a Hold and lowers the price target from $1.55 to...

standard-biotools-affirms-fy2025-sales-guidance-of-165000m-175000m-vs-86360m-est
Standard BioTools Affirms FY2025 Sales Gui...
11/04/2025 21:08:29

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.000 million-$175.000 million to $165.000 million-$175.000...

standard-biotools-q3-eps-009-misses-006-estimate-sales-19552m-beat-17998m-estimate
Standard BioTools Q3 EPS $(0.09) Misses $(...
11/04/2025 21:07:46

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

standard-biotools-commences-restructuring-plan-including-15-workforce-reduction
Standard BioTools Commences Restructuring ...
09/17/2025 20:07:54

-SEC Filing

standard-biotools-affirms-fy2025-sales-guidance-of-165000m-175000m-vs-169148m-est
Standard BioTools Affirms FY2025 Sales Gui...
08/11/2025 20:41:31

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.000 million-$175.000 million to $165.000 million-$175.000...

standard-biotools-q2-eps-from-continuing-operations-005
Standard BioTools Q2 EPS From Continuing O...
08/11/2025 20:02:35

standard-biotools-q2-eps-009-misses-008-estimate-sales-41962m-beat-39824m-estimate
Standard BioTools Q2 EPS $(0.09) Misses $(...
08/11/2025 20:02:18

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

standard-biotools-and-precise-sg100k-launch-proteomics-collaboration-with-somascan-11k-to-analyze-100000-singapore-biobank-samples
Standard BioTools And PRECISE-SG100K Launc...
08/06/2025 11:18:42

fedex-issues-soft-guidance-joins-torrid-holdings-allot-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
FedEx Issues Soft Guidance, Joins Torrid H...
06/25/2025 12:36:28

somalogic-acquisition-marks-next-step-in-illuminas-advanced-biomarker-push
SomaLogic Acquisition Marks Next Step In I...
06/23/2025 16:04:58

Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multio...

tesla-spartannash-standard-biotools-and-other-big-stocks-moving-higher-on-monday
Tesla, SpartanNash, Standard BioTools And ...
06/23/2025 15:07:56

Core News & Articles
CORRECTION: Standard BioToles Ticker Is "L...
06/23/2025 13:08:20

Core News & Articles
Standard BioTools Sells SomaLogic To Illum...
06/23/2025 11:10:06

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash  Retains Strategic...

standard-biotools-affirms-fy2025-sales-guidance-of-16500m-17500m-vs-16920m-est
Standard BioTools Affirms FY2025 Sales Gui...
05/06/2025 20:02:40

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.00 million-$175.00 million to $165.00 million-$175.00 mil...

standard-biotools-q1-eps-007-inline-sales-4080m-beat-4010m-estimate
Standard BioTools Q1 EPS $(0.07), Inline, ...
05/06/2025 20:02:23

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

keybanc-downgrades-standard-biotools-to-sector-weight
Keybanc Downgrades Standard BioTools to Se...
02/27/2025 13:07:55

Keybanc analyst Paul Knight downgrades Standard BioTools (NASDAQ:LAB) from Overweight to Sector Weight.

standard-biotools-sees-fy2025-sales-165000m-175000m-vs-18693m-est
Standard BioTools Sees FY2025 Sales $165.0...
02/26/2025 21:11:53

Standard BioTools (NASDAQ:LAB) sees FY2025 sales of $165.000 million-$175.000 million vs $186.93 million analyst estimate.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION